Log In
BCIQ
Print this Print this
 

WCK 2349

  Manage Alerts
Collapse Summary General Information
Company Wockhardt Ltd.
DescriptionOral broad-spectrum antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MSRA) infection
Regulatory Designation U.S. - Qualified Infectious Disease Program (Treat methicillin-resistant Staphylococcus aureus (MSRA) infection)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today